T0	Participants 29 53	non-Hodgkin's lymphomas.
T1	Participants 55 271	Between July 1, 1971 and December 31, 1978, 150 patients with favorable subtypes of non-Hodgkin's lymphoma [nodular poorly differentiated lymphocytic (NLPD), nodular mixed, or diffuse well differentiated lymphocytic]
T2	Participants 313 352	clinical trials at Stanford University.